You’re more than what meets the eye. Living with IgA nephropathy (IgAN) means carrying an invisible burden others can’t see. Researchers are working to bring your hidden challenges into focus and discover potential treatment options for IgAN.
You may be able to participate in the A.M.IgA. Study if you:
Are at least 18 years of age
Have been diagnosed with IgA nephropathy (IgAN)
Have been on stable therapy for IgAN for at least 12 weeks
Have no other disease that affects your kidneys
If you are interested in participating, the study doctor or staff will review additional study criteria with you.
Travel-related support as well as compensation for time spent during site visits or meal allowance for this study may be available depending on country and site regulatory approvals. The investigational medication, placebo, and all study-related tests will be provided to participants during their study participation.
IgAN is a kidney disease in which a defective form of a certain protein (immunoglobulin A) accumulates in the kidneys. This protein buildup can affect the kidneys' ability to filter waste from the blood.
IgAN is diagnosed most often in people between the ages of 10 and 40.
Symptoms may include blood in the urine, foamy urine, and swelling in hands and feet.
IgAN is more common in people who are assigned male at birth.
